Xu Zhenyu — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Xu Zhenyu has filed 6 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $172K.

Profile

Xu Zhenyu is the Chief Scientific Officer at SOPHiA GENETICS SA, a company specializing in data-driven medicine and genomic analysis. He has a strong background in bioinformatics and molecular biology, contributing significantly to the development of innovative solutions in genomic data interpretation.

Board memberships

• SOPHiA GENETICS SA

Awards & honors

• Leading the development of genomic data analysis tools
• Contributing to advancements in personalized medicine

Recent Transactions

Companies — Last 90 Days

• SOPHiA GENETICS SA (SOPH) — 6 filings, last 2026-07-14

Frequently Asked Questions

Who is Xu Zhenyu?

Xu Zhenyu is the Chief Scientific Officer at SOPHiA GENETICS SA, a company specializing in data-driven medicine and genomic analysis. He has a strong background in bioinformatics and molecular biology, contributing significantly to the development of innovative solutions in genomic data interpretation.…

How many SEC Form 4 filings has Xu Zhenyu submitted recently?

6 primary Form 4 filings in the last 90 days, covering 1 company.

Has Xu Zhenyu been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 13 open-market sales ($172K) across all tracked filings.

Where can I see all of Xu Zhenyu's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week